Home/Filings/4/0001140361-17-014420
4//SEC Filing

Asterias Biotherapeutics, Inc. 4

Accession 0001140361-17-014420

CIK 0001572552operating

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:03 PM ET

Size

6.5 KB

Accession

0001140361-17-014420

Insider Transaction Report

Form 4
Period: 2017-03-30
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2017-03-30+32,783292,783 total
  • Award

    Stock Options

    2017-03-30+200,000200,000 total
    Exercise: $3.45From: 2017-03-30Exp: 2027-03-29Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The stock options reported herein vest as follows: one quarter of the options vest upon on the one year anniversary of the date of grant, and the remaining options vest in 36 equal monthly installments thereafter.

Issuer

Asterias Biotherapeutics, Inc.

CIK 0001572552

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001572552

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:03 PM ET
Size
6.5 KB